Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Seroprevalence of hepatitis A in children and adolescents.

Markus JR, Cruz CR, Maluf EM, Tahan TT, Hoffmann MM.

J Pediatr (Rio J). 2011 Sep-Oct;87(5):419-24. doi: doi:10.2223/JPED.2119. Epub 2011 Aug 12. English, Portuguese.

2.

Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.

Vitral CL, Ospina FL, Artimos S, Melgaço JG, Cruz OG, de Paula VS, Luz SB, Freire M, Gaspar LP, Amado LA, Engstrom EM, Fortes CD, Souza TC, Dias MN, Gaspar AM, Souto FJ.

Mem Inst Oswaldo Cruz. 2012 Aug;107(5):652-8.

3.

Hepatitis a in Lebanon: a changing epidemiological pattern.

Sacy RG, Haddad M, Baasiri G, Khoriati A, Gerbaka BJ, Abu-Elyazeed R.

Am J Trop Med Hyg. 2005 Aug;73(2):453-6.

PMID:
16103621
4.

Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.

Al-Aziz AM, Awad MA.

East Mediterr Health J. 2008 Sep-Oct;14(5):1028-35.

PMID:
19161074
5.

Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.

Dhawan PS, Shah SS, Alvares JF, Kher A, Shankaran, Kandoth PW, Sheth PN, Kamath H, Kamath A, Koppikar GV, Kalro RH.

Indian J Gastroenterol. 1998 Jan;17(1):16-8.

PMID:
9465507
6.

Prevalence of anti-hepatits A antibodies in children of different socioeconomic conditions in Vila Velha, ES.

Zago-Gomes MP, Stantolin GC, Perazzio S, Aikawa KH, Gonçalves CS, Pereira FE.

Rev Soc Bras Med Trop. 2005 Jul-Aug;38(4):285-9. Epub 2005 Aug 3.

7.

Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.

Moisseeva AV, Marichev IL, Biloschitchkay NA, Pavlenko KI, Novik LV, Kovinko LV, Lyabis OI, Houillon G, Rasuli AM.

J Viral Hepat. 2008 Oct;15 Suppl 2:43-6. doi: 10.1111/j.1365-2893.2008.01028.x.

PMID:
18837833
8.

Hepatitis A seroprevalence in children and adolescents aged 1-18 years among a low socioeconomic population in Izmir, Turkey.

Halicioglu O, Akman SA, Tatar B, Atesli R, Kose S.

Travel Med Infect Dis. 2012 Jan;10(1):43-7. doi: 10.1016/j.tmaid.2012.01.001. Epub 2012 Jan 20.

PMID:
22264583
9.

Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.

Lee D, Cho YA, Park Y, Hwang JH, Kim JW, Kim NY, Lee DH, Lee W, Jeong SH.

Intervirology. 2008;51(2):70-4. doi: 10.1159/000127428. Epub 2008 Apr 22.

PMID:
18434743
11.

A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.

Lee D, Ki M, Lee A, Lee KR, Park HB, Kim CS, Yoon BY, Kim JH, Lee YS, Jeong SH.

Korean J Hepatol. 2011 Mar;17(1):44-50. doi: 10.3350/kjhep.2011.17.1.44.

12.

Shifting susceptibility to hepatitis A among children and adolescents over the past decade.

Krebs LS, Ranieri TM, Kieling CO, Ferreira CT, Silveira TR.

J Pediatr (Rio J). 2011 May-Jun 8;87(3):213-8. doi: doi:10.2223/JPED.2088. Epub 2011 Apr 5. English, Portuguese.

13.

Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.

Zhu Y, Yuan Z, Zhao Q, Chen G, Xu B.

Epidemiol Infect. 2013 Mar;141(3):556-62. doi: 10.1017/S0950268812001161. Epub 2012 Jun 12.

PMID:
22687628
14.

Hepatitis A virus subgenotypes dissemination during a community outbreak in a surrounding region of Rio de Janeiro.

Santos DR, Villar LM, Paula VS, Lima GS, Gaspar AM.

Mem Inst Oswaldo Cruz. 2008 May;103(3):254-8.

15.

Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.

Ceyhan M, Yildirim I, Kurt N, Uysal G, Dikici B, Ecevit C, Aydogan A, Koc A, Yasa O, Köseoğlu M, Onal K, Hacimustafaoglu M, Celebi S.

J Viral Hepat. 2008 Oct;15 Suppl 2:69-72. doi: 10.1111/j.1365-2893.2008.01034.x.

PMID:
18837839
16.

Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.

Richardus JH, Vos D, Veldhuijzen IK, Groen J.

J Med Virol. 2004 Feb;72(2):197-202.

PMID:
14695660
17.

Age related seroprevalence of antibodies to hepatitis A virus in Hyderabad, India.

Joshi N, Yr NK, Kumar A.

Trop Gastroenterol. 2000 Apr-Jun;21(2):63-5.

PMID:
10881625
18.

[Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].

Chlíbek R, Cecetková B, Smetana J, Prymula R, Kohl I.

Epidemiol Mikrobiol Imunol. 2006 Aug;55(3):99-104. Czech.

PMID:
16970073
19.

Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.

Lazcano-Ponce E, Conde-Gonzalez C, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E.

Hum Vaccin Immunother. 2013 Feb;9(2):375-81. Epub 2013 Jan 4.

20.

Changing epidemiology of hepatitis A infection in Izmir, Turkey.

Kurugol Z, Aslan A, Turkoglu E, Koturoglu G.

Vaccine. 2011 Aug 26;29(37):6259-61. doi: 10.1016/j.vaccine.2011.06.069. Epub 2011 Jul 18.

PMID:
21763745

Supplemental Content

Support Center